FLEXIBLE RADIO AND INTERCOM INTERFACE
A new software programmable, binaural interface for user defined stereo or split ear capabilities. Compatible with all current and future communication systems.
A new software programmable, binaural interface for user defined stereo or split ear capabilities. Compatible with all current and future communication systems.
EXTENDED FUNCTIONALITY
A selectable ‘whisper’ mode that enables extended use in low noise operations.
A selectable ‘whisper’ mode that enables extended use in low noise operations.
INCREASED USER CONTROL - DUAL CHANNEL WIRELESS PTT
Up to 5 wireless PTT remote control devices can be simultaneously used with a QUIETPRO+ system. Optional wired PTT controls are also available.
Up to 5 wireless PTT remote control devices can be simultaneously used with a QUIETPRO+ system. Optional wired PTT controls are also available.
QUALIFIED AND APPROVED
Following extensive testing and evaluation during 2008, the QUIETPRO® is the only in-ear communications device approved for use by the US Army.
Following extensive testing and evaluation during 2008, the QUIETPRO® is the only in-ear communications device approved for use by the US Army.
THE QUIETPRO+ IS AVAILABLE TODAY!
Contact us to request your demonstration and evaluation units.
Contact us to request your demonstration and evaluation units.
Neurofibromatosis treatment AR-42
ReplyDeleteArno Medical treatment of type 2 multiple neurofibroma Drug AR-42 issued by the European Commission recently received orphan drug designation accreditation. AR-42 is a suitable non-histones and histone deacetylase inhibitors spectrum.
In preclinical studies, such oral inhibitor of the entity in the treatment of tumors and hematological malignancies shows good efficacy and activity.
The ongoing Phase AR-42 Ⅰ, Ⅱ a period of research, mainly for multiple hematologic malignancies and solid tumors.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
ENMD-2076 TARTARIC ACID
ENMD-2076
SNS-314
CCT129202
Hesperadin
PF-03814735
AT9283
GSK-1070916
MK-5108
Aurora A inhibitor I